IBDEI1D2 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24403,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,24404,0)
 ;;=250.01^^159^1568^5
 ;;^UTILITY(U,$J,358.3,24404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24404,1,3,0)
 ;;=3^250.01
 ;;^UTILITY(U,$J,358.3,24404,1,4,0)
 ;;=4^DM Type I,not uncontrolled
 ;;^UTILITY(U,$J,358.3,24404,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,24405,0)
 ;;=782.3^^159^1568^10
 ;;^UTILITY(U,$J,358.3,24405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24405,1,3,0)
 ;;=3^782.3
 ;;^UTILITY(U,$J,358.3,24405,1,4,0)
 ;;=4^Edema
 ;;^UTILITY(U,$J,358.3,24405,2)
 ;;=^38340
 ;;^UTILITY(U,$J,358.3,24406,0)
 ;;=278.00^^159^1568^19
 ;;^UTILITY(U,$J,358.3,24406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24406,1,3,0)
 ;;=3^278.00
 ;;^UTILITY(U,$J,358.3,24406,1,4,0)
 ;;=4^Obesity
 ;;^UTILITY(U,$J,358.3,24406,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,24407,0)
 ;;=280.9^^159^1568^14
 ;;^UTILITY(U,$J,358.3,24407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24407,1,3,0)
 ;;=3^280.9
 ;;^UTILITY(U,$J,358.3,24407,1,4,0)
 ;;=4^Iron Defic Anemia
 ;;^UTILITY(U,$J,358.3,24407,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,24408,0)
 ;;=780.79^^159^1568^17
 ;;^UTILITY(U,$J,358.3,24408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24408,1,3,0)
 ;;=3^780.79
 ;;^UTILITY(U,$J,358.3,24408,1,4,0)
 ;;=4^Malaise And Fatigue
 ;;^UTILITY(U,$J,358.3,24408,2)
 ;;=^73344
 ;;^UTILITY(U,$J,358.3,24409,0)
 ;;=783.21^^159^1568^21
 ;;^UTILITY(U,$J,358.3,24409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24409,1,3,0)
 ;;=3^783.21
 ;;^UTILITY(U,$J,358.3,24409,1,4,0)
 ;;=4^Weight Loss, Abnormal
 ;;^UTILITY(U,$J,358.3,24409,2)
 ;;=^322005
 ;;^UTILITY(U,$J,358.3,24410,0)
 ;;=250.90^^159^1568^9
 ;;^UTILITY(U,$J,358.3,24410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24410,1,3,0)
 ;;=3^250.90
 ;;^UTILITY(U,$J,358.3,24410,1,4,0)
 ;;=4^Dm Type II, With Comp
 ;;^UTILITY(U,$J,358.3,24410,2)
 ;;=^33626
 ;;^UTILITY(U,$J,358.3,24411,0)
 ;;=250.91^^159^1568^8
 ;;^UTILITY(U,$J,358.3,24411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24411,1,3,0)
 ;;=3^250.91
 ;;^UTILITY(U,$J,358.3,24411,1,4,0)
 ;;=4^Dm Type I, With Comp
 ;;^UTILITY(U,$J,358.3,24411,2)
 ;;=^267850
 ;;^UTILITY(U,$J,358.3,24412,0)
 ;;=278.01^^159^1568^18
 ;;^UTILITY(U,$J,358.3,24412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24412,1,3,0)
 ;;=3^278.01
 ;;^UTILITY(U,$J,358.3,24412,1,4,0)
 ;;=4^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,24412,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,24413,0)
 ;;=278.02^^159^1568^20
 ;;^UTILITY(U,$J,358.3,24413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24413,1,3,0)
 ;;=3^278.02
 ;;^UTILITY(U,$J,358.3,24413,1,4,0)
 ;;=4^Overweight
 ;;^UTILITY(U,$J,358.3,24413,2)
 ;;=^332745
 ;;^UTILITY(U,$J,358.3,24414,0)
 ;;=250.02^^159^1568^6
 ;;^UTILITY(U,$J,358.3,24414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24414,1,3,0)
 ;;=3^250.02
 ;;^UTILITY(U,$J,358.3,24414,1,4,0)
 ;;=4^DM Type II,Uncontrolled
 ;;^UTILITY(U,$J,358.3,24414,2)
 ;;=^331781
 ;;^UTILITY(U,$J,358.3,24415,0)
 ;;=250.03^^159^1568^4
 ;;^UTILITY(U,$J,358.3,24415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24415,1,3,0)
 ;;=3^250.03
 ;;^UTILITY(U,$J,358.3,24415,1,4,0)
 ;;=4^DM Type I, Uncontrolled
 ;;^UTILITY(U,$J,358.3,24415,2)
 ;;=^331782
 ;;^UTILITY(U,$J,358.3,24416,0)
 ;;=V58.67^^159^1568^16
 ;;^UTILITY(U,$J,358.3,24416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24416,1,3,0)
 ;;=3^V58.67
 ;;^UTILITY(U,$J,358.3,24416,1,4,0)
 ;;=4^Long-Term Use of Insulin
 ;;^UTILITY(U,$J,358.3,24416,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,24417,0)
 ;;=780.60^^159^1568^11
 ;;^UTILITY(U,$J,358.3,24417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24417,1,3,0)
 ;;=3^780.60
